Sumitomo Mitsui Trust Group Inc. Has $211.40 Million Position in CME Group Inc. (NASDAQ:CME)

Sumitomo Mitsui Trust Group Inc. grew its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 0.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 958,085 shares of the financial services provider's stock after buying an additional 8,561 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.27% of CME Group worth $211,401,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in CME. Empowered Funds LLC raised its stake in shares of CME Group by 24.5% during the 1st quarter. Empowered Funds LLC now owns 5,596 shares of the financial services provider's stock worth $1,205,000 after purchasing an additional 1,101 shares in the last quarter. Avantax Advisory Services Inc. increased its holdings in CME Group by 4.5% in the first quarter. Avantax Advisory Services Inc. now owns 7,415 shares of the financial services provider's stock worth $1,596,000 after buying an additional 318 shares during the last quarter. Edmond DE Rothschild Holding S.A. raised its position in CME Group by 102.1% during the first quarter. Edmond DE Rothschild Holding S.A. now owns 4,741 shares of the financial services provider's stock valued at $1,021,000 after acquiring an additional 2,395 shares in the last quarter. Entropy Technologies LP acquired a new stake in CME Group in the first quarter valued at approximately $730,000. Finally, Koshinski Asset Management Inc. bought a new stake in CME Group in the first quarter worth approximately $244,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Timothy S. Bitsberger sold 1,000 shares of the company's stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now owns 10,589 shares of the company's stock, valued at $2,403,279.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the company's stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares of the company's stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last 90 days. Corporate insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

CME has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised their price target on shares of CME Group from $187.00 to $191.00 and gave the company an "underweight" rating in a report on Thursday, July 25th. Morgan Stanley raised their target price on CME Group from $210.00 to $233.00 and gave the company an "equal weight" rating in a report on Thursday, October 17th. Redburn Atlantic downgraded CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price target for the company. in a research note on Tuesday, October 8th. Piper Sandler raised their price objective on CME Group from $240.00 to $250.00 and gave the company an "overweight" rating in a research note on Monday, October 28th. Finally, Barclays upped their target price on CME Group from $219.00 to $231.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $224.47.

CME Group Stock Performance

NASDAQ CME traded up $1.83 during midday trading on Wednesday, hitting $228.14. The company had a trading volume of 1,959,988 shares, compared to its average volume of 1,913,960. The firm has a fifty day simple moving average of $222.20 and a two-hundred day simple moving average of $210.04. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market cap of $82.15 billion, a price-to-earnings ratio of 23.89, a P/E/G ratio of 5.69 and a beta of 0.55.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the business earned $2.25 earnings per share. Equities analysts forecast that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.02%. CME Group's dividend payout ratio (DPR) is currently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.